UB872
ProductHeparin Sodium Injection
Strength1mL:5000iu
IndicationsThromboembolism prophylaxis; Thromboembolism; Anticoagulation therapy; Extracorporeal circulation; Dialysis; In vitro anticoagulation
TherapeuticsCardiovascular; Blood and Blood Forming Organs
GMPUS - FDA; CN - NMPA
RegistrationUnited States; China
ModalitiesSmall Molecule
Exclusive Summary
- Backed by US-FDA GMP and US market registration, offering the highest tier of quality endorsement to fast-track market access and distributor confidence globally.
- Listed as a WHO Essential Medicine, it addresses a massive, rigid global demand of tens of millions of patients across hemodialysis, cardiovascular surgeries, and VTE treatments.
- Positioned to resolve frequent global heparin supply shortages by leveraging China's vertical API integration, ensuring distributors highly competitive pricing and resilient supply chains.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →